Supporting Systems-Level Drug Discovery
At Systasy, we believe that multiplexing truly matters for gaining early-on knowledge of disease-related cellular mechanisms. The large number of different events involved in cellular signaling calls for an integrated analysis.
Compared to traditional HTS strategies in drug discovery, our systems-level approach termed High Content Profiling (HCP) adds tremendous value through delivering more reliable, complete and integrated data on these complex cellular signaling events.
HCP can be applied in neurobiological test systems, such as in primary mouse neurons and human iPSC-derived disease models.